Clene Inc. (CLNN)vsMcCormick & Company Incorporated (MKC-V)
CLNN
Clene Inc.
$4.03
+1.51%
CONSUMER DEFENSIVE · Cap: $53.02M
MKC-V
McCormick & Company Incorporated
$46.05
-3.60%
CONSUMER DEFENSIVE · Cap: $13.01B
Smart Verdict
WallStSmart Research — data-driven comparison
McCormick & Company Incorporated generates 3901271% more annual revenue ($7.69B vs $197,000). MKC-V leads profitability with a 19.4% profit margin vs 0.0%. MKC-V earns a higher WallStSmart Score of 59/100 (C).
CLNN
Avoid32
out of 100
Grade: F
MKC-V
Buy59
out of 100
Grade: C
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-78.8%
Fair Value
$2.31
Current Price
$4.03
$1.72 premium
Margin of Safety
+77.9%
Fair Value
$325.30
Current Price
$46.05
$279.25 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 233.3% year-over-year
Earnings expanding 61.4% YoY
Conservative balance sheet, low leverage
Attractively priced relative to earnings
Every $100 of equity generates 21 in profit
Reasonable price relative to book value
17.4% revenue growth
Areas to Watch
Smaller company, higher risk/reward
0.0% margin — thin
Weak financial health signals
ROE of -1738.0% — below average capital efficiency
Expensive relative to growth rate
Distress zone — elevated risk
Earnings declined 57.1%
Comparative Analysis Report
WallStSmart ResearchBull Case : CLNN
The strongest argument for CLNN centers on Revenue Growth, EPS Growth, Debt/Equity. Revenue growth of 233.3% demonstrates continued momentum.
Bull Case : MKC-V
The strongest argument for MKC-V centers on P/E Ratio, Return on Equity, Price/Book. Profitability is solid with margins at 19.4% and operating margin at 17.8%. Revenue growth of 17.4% demonstrates continued momentum.
Bear Case : CLNN
The primary concerns for CLNN are Market Cap, Profit Margin, Piotroski F-Score.
Bear Case : MKC-V
The primary concerns for MKC-V are PEG Ratio, Altman Z-Score, EPS Growth.
Key Dynamics to Monitor
CLNN profiles as a hypergrowth stock while MKC-V is a growth play — different risk/reward profiles.
CLNN carries more volatility with a beta of 0.92 — expect wider price swings.
CLNN is growing revenue faster at 233.3% — sustainability is the question.
MKC-V generates stronger free cash flow (112M), providing more financial flexibility.
Bottom Line
MKC-V scores higher overall (59/100 vs 32/100), backed by strong 19.4% margins and 17.4% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Clene Inc.
CONSUMER DEFENSIVE · PACKAGED FOODS · USA
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of new clean-surface nanotechnology (CSN) therapies. The company is headquartered in Salt Lake City, Utah.
McCormick & Company Incorporated
CONSUMER DEFENSIVE · PACKAGED FOODS · USA
McCormick & Company is an American multinational food company that manufactures, markets, and distributes spices, seasoning mixes, condiments, and other flavoring products to retail outlets, food manufacturers, and foodservice businesses.
Compare with Other PACKAGED FOODS Stocks
Want to dig deeper into these stocks?